US Archives - Page 87 of 137 - European Medical Journal

COVID-19 Overtakes Flu and RSV in Long-Term Mortality Risk

Over 141,000 nonhospitalized U.S. veterans were included in a new study that has provided new insights into the relative severity and long-term mortality associated with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).

Ketogenic Diet May Exacerbate Osteoarthritis and Pain

A ketogenic diet (KD) may worsen osteoarthritis (OA) severity and increase pain sensitivity according to the results of a new study.

Functional Biomarkers: A New Tool in Melanoma Immunotherapy

Understanding why some patients with melanoma respond to immunotherapy while others do not has remained a critical challenge for precision medicine.

Innovative Approach Enhances Outcomes in Metastatic NSCLC

A recent multicenter Phase II trial has demonstrated that combining chemoradiotherapy (CRT) with aggressive local consolidative therapy (LCT) can improve survival rates in patients with Stage IV non-small cell lung carcinoma (NSCLC) presenting with oligometastases.

Kansas TB Outbreak Demands Immediate Medical Attention

Kansas is grappling with a significant tuberculosis (TB) outbreak, reporting 67 active cases, 60 in Wyandotte County and seven in Johnson County, and 79 confirmed latent TB infections, predominantly in Wyandotte County.

Brain Wave Patterns Linked to Pain Sensitivity

A recent cohort study has identified a novel cortical biomarker signature that accurately predicts individual pain sensitivity, offering promising implications for the diagnosis, prevention, and treatment of chronic pain.

HIV Linked To Threefold Increased Coronary Risk

A recent prospective matched cohort study has revealed that individuals living with HIV (PWH) face a significantly higher risk of developing subclinical coronary atherosclerosis compared to the general population.

Immune Checkpoint Inhibitors: A Balancing Act

Risks of autoimmune conditions (ACs) in patients treated with immune checkpoint inhibitors (ICIs), a critical class of cancer immunotherapies, have been explored in a new epidemiological study.

Combining Oral and UV Therapy for Vitiligo

A recent clinical trial has shown promising results in treating severe, active vitiligo through a combination of oral medication and phototherapy, offering new hope for managing this challenging condition.

New Trial Advances Basal Cell Carcinoma Treatment

A Phase II trial examining neoadjuvant therapy for difficult-to-resect cutaneous basal cell carcinoma (BCC) demonstrates promising outcomes.